HOME >> MEDICINE >> NEWS
New Data Show Evista Reduces Spinal Fractures

New Data Show Lilly's Evista® Significantly Reduces Spinal Fractures With Two Years of Therapy
Medical Meeting To Highlight Results From the MORE Study

Eli Lilly and Company's Evista® (raloxifene hydrochloride), the newest osteoporosis preventive, significantly reduced by about half the risk of new spinal fractures among postmenopausal women after two years of treatment, according to data presented today. These interim data were reported by Bruce Ettinger, M.D., senior investigator, division of research, Kaiser Permanente Medical Care Program, at the annual meeting of the European Congress on Osteoporosis in Berlin, Germany.

"These data are the first to show that a selective estrogen receptor modulator can significantly reduce the risk of spinal fracture," said August M. Watanabe, M.D., Lilly executive vice president, science and technology. "The results from this interim analysis provide further support that Evista protects a woman's bones and may address other health concerns important after menopause."

Two-year results from osteoporosis treatment studies
Ettinger's report analyzes 7,705 postmenopausal women enrolled in the ongoing Multiple Outcomes of Raloxifene Evaluation (MORE) study, a double-blind, placebo-controlled, randomized clinical trial designed primarily to evaluate the effect of daily Evista therapy on bone mineral density (BMD) and spinal fractures in women who have osteoporosis.

Women in the MORE study were on average 66 and one-half years old upon entry into the trial and have osteoporosis. The two-year analysis demonstrates that women taking Evista who had no spinal fractures upon entry into the study were 52 percent less likely to have a first spinal fracture and women with a previous spinal fracture were 38 percent less likely to have new spinal fractures when compared with their counterparts taking placebo supp
'"/>

Contact: Laura Miller
MILLER_LAURA_N@LILLY.COM
(317) 277-1172
Eli Lilly and Company
14-Sep-1998


Page: 1 2 3 4

Related medicine news :

1. Osteoporosis Drug Evista (Raloxifene) Cuts Newly Diagnosed, Invasive Breast Cancer Risk By More Than 60 Percent
2. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
3. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
4. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. AVANT Atherosclerosis Vaccine Raises HDL, Reduces Atherosclerosis In Vaccinated Animals
6. Inhibiting Growth Of New Blood Vessels Reduces Heart Disease Plaque In Mice
7. Intravenous Immunoglobulin Reduces Steroid Insensitivity, Hospitalizations Of People With Severe Asthma, According To National Jewish Research
8. UCSF Study Shows Drug Reduces Risk Of Spine And Hip Fractures By Half In Women With Osteoporosis
9. Scientists Discover How Aspirin Reduces Inflammation
10. Novel Therapy Significantly Reduces Spinal Fractures In Postmenopausal WomenWith Two Years Of Therapy
11. Drug Reduces Heart Attack, Death Rates In Patients With Unstable Angina

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... April 18, 2019 , ... Dr. Matt Nejad is a ... full menu of cosmetic and general dental care services. Dr. Nejad is most ... relies on minimally-invasive techniques in restorative dentistry. Biomimetic dentistry uses a more holistic ...
(Date:4/17/2019)... GULF BREEZE, Fla. (PRWEB) , ... April 17, 2019 , ... ... in the headlines, scientists are working to curb the death toll by looking for ... Society Spring 2019 National Meeting & Exposition this week. , Naloxone (often known ...
(Date:4/17/2019)... ... April 17, 2019 , ... Purple Biosciences today introduces Purple ... supplement was designed to lessen the negative effects of alcohol, so adults can ... GotPurpleTree.com and Amazon.com . , According to the Centers for Disease ...
(Date:4/17/2019)... ... April 17, 2019 , ... Signaled.online is a notification service designed ... alarm, monitoring of the web resources and reminder. , The alarm can be useful ... live alone. If you haven’t logged in to the website for several days (this ...
(Date:4/17/2019)... ... April 17, 2019 , ... Nastel Technologies is a ... Management (APM) for mission-critical applications in the mixed cloud environments. Nastel is entering ... XRay® for MQ. , Nastel XRay® for MQ, a Big Data analytics platform ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... April 17, 2019 , ... ... Pennsylvania, Allegheny Health Network (AHN) and Gateway Health have launched a new program ... of life. , AHN’s Enhanced Pain Management Program brings together a range ...
(Date:4/17/2019)... , ... April 17, 2019 , ... The Job ... that will support investigation into the causes of and treatments for Job Syndrome. ... projects that will take place around the globe in three countries, and on three ...
(Date:4/17/2019)... ... April 17, 2019 , ... With the US Food ... to Expedite Development of Oncology Drugs and Biologics’ – it opens ... years of experience helping sponsors manage complex oncology trials, endpoint has ...
Breaking Medicine Technology:
Cached News: